Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Marinus Pharma CS (NQ: MRNS )

10.80 USD +0.26 (+2.47%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 19, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 138,494
Open 10.54
Bid (Size) 10.30 (1)
Ask (Size) 11.80 (1)
Prev. Close 10.54
Today's Range 10.53 - 11.06
52wk Range 9.100 - 20.04
Shares Outstanding 36,766,355
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Canadian Biotech Disruptor Lexston Life Sciences is unlocking the God Molecule (LEXTF, ICPT, AKBA, QURE, BNTX, SAVA)
Tags U/S Personal Finance Finance
From AB Newswire
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) 
From Business Wire News Releases

Performance

YTD
-17.18%
-17.18%
1 Month
+2.18%
+2.18%
3 Month
-4.68%
-4.68%
6 Month
-33.82%
-33.82%
1 Year
-14.76%
-14.76%

More News

Read More
Marinus Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright Bioconnect Conference
From Business Wire News Releases
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
From Business Wire News Releases
Marinus Pharmaceuticals Announces New Clinical and Research Data to be Presented at American Epilepsy Society Meeting
From Business Wire News Releases
Marinus Pharmaceuticals Announces Nine Presentations and Virtual Investor Event at American Epilepsy Society 2021 Annual Meeting
From Business Wire News Releases
Marinus Pharmaceuticals to Present at Multiple Upcoming Investor Conferences
From Business Wire News Releases
Analysts Anticipate XPH To Hit $69
Tags ETFs
From ETF Channel
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2021 Financial Results
From Business Wire News Releases
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Business Wire News Releases
Marinus Pharmaceuticals to Provide Business Update and Announce Third Quarter 2021 Financial Results on November 9, 2021
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]